With the outrage of anti-alcohol groups laws could be tightened but many experts feel that it is not the alcohol that needs to be focused on however the people who over-indulge. According to figures compiled for the National Drug Survey, a lot of people aged 12 to 17 say accessing alcohol is certainly either easy or very easy. They often depend on older siblings to buy alcohol and pass it in legally. Even more disappointing, in at least 34 percent of cases, kids under 18 were consistently getting alcohol from their parents.Iclusig is commercially available in the U.S. And EU for sufferers with resistant or intolerant CML and Philadelphia-chromosome positive acute lymphoblastic leukemia. ARIAD continues to work with health authorities to create appropriate changes to the Iclusig product labeling to reflect the lately announced safety findings from the pivotal Speed trial that was the foundation of its marketing approvals.. Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancers and orphan diseases, announced the initiation of a stage 2 study of it is investigational proteins therapeutic today, ACE-536, to take care of anemia in individuals with myelodysplastic syndromes . MDS are a band of hematologic malignancies of the bone marrow that bring about low levels of a number of types of bloodstream cells resulting most commonly in serious and chronic anemia .